Email: info@ivascular.global | Tel: +34 936 724 711
EN
Site logo
Sticky header logo
  • About us
    • Company
    • Philosophy
    • Vertical integration
    • Group
    • iVascular worldwide
  • Therapeutic areas
    • Coronary
      • angiolite
      • essential pro
      • essential
      • navitian
      • architect
      • capturer
      • xperience
      • NC xperience
      • xperience pro
    • Peripheral
      • luminor
      • iVolution
      • restorer
      • angiolite BTK
      • oceanus
      • nautilus
  • Clinical Trials
    • EFFPAC Trial
    • ANGIOLITE Trial
    • ANCHOR Trial
    • EVOLUTION Trial
    • LUMINOR Registry
    • TINTIN Trial
    • ANGIOLITE BTK Trial
    • MERLION Trial
    • BIBLIOS Trial
    • ESSENTIAL in Small Vessels Registry
    • RANGO Registry
    • ESSENTIAL ISR Trial
  • Healthcare Professionals
    • Interactive Vascular Summit
    • PMS
      • luminor DCB
      • angiolite DES
      • Peripheral stents
      • essential – essential pro
    • innoVasc
    • iVascular Grant
  • Careers
    • Work with us
    • Jobs board
  • News
  • Contact
Site logo
Sticky header logo
Site logo
Sticky header logo
EN

Blog categories

  • All (16)
  • Clinical Trials (19)
  • Congresses (16)
  • Coronary (8)
  • Coronary and peripheral news (9)
  • Partnership (3)
  • Peripheral (19)

Comments

    All iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.
    June 26, 2020

    iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session.

    Read more
    All iVascular COVID 19 letter
    June 15, 2020

    iVascular COVID 19 letter

    Read more
    All iVascular – essential pro, new coronary drug coated balloon
    June 15, 2020

    iVascular – essential pro, new coronary drug coated balloon

    Read more
    Congresses iVascular, innovation and passion at the interactive Vascular Summit 2020.
    March 2, 2020

    iVascular, innovation and passion at the interactive Vascular Summit 2020.

    Read more
    All TINTIN Trial 1-year outcomes presented at LINC 2020
    January 30, 2020

    TINTIN Trial 1-year outcomes presented at LINC 2020

    Read more
    All ANGIOLITE trial 2 years outcomes have been published at EuroIntervention
    January 22, 2020

    ANGIOLITE trial 2 years outcomes have been published at EuroIntervention

    Read more
    All Lumbra Registry en Brasil
    December 3, 2019

    LUMBRA, a registry for real world lesions with luminor DCB in Brazil

    Read more
    Coronary and peripheral news Innovasc Winner 2019
    October 31, 2019

    iVascular’s first open innovation initiative, innoVasc, is pleased to announce the winner of the grant.

    Read more
    Peripheral Luminor DCB is now Reimbrused in France
    October 10, 2019

    luminor DCB is now reimbursed in France.

    Read more
    Peripheral TINTIN Trial 6 month outcomes
    September 24, 2019

    TINTIN trial shows impressive results at 6-months.

    Read more
    Coronary and peripheral news The open innovation initiative
    May 29, 2019

    iVascular launches innoVasc, a new open innovation program that tackles the current and future challenges of vascular therapies.

    Read more
    Coronary and peripheral news New Stdy Essential
    May 28, 2019

    New study in ISR with essential DCB presented at EuroPCR 2019.

    Read more
    Prev

    Posts navigation

    • 1
    • 2
    • 3
    • 4
    • 5
    Next

    Search

    Recent Posts

    • iVascular- MERLION Trial 6-month outcomes have been presented at VIVA 2020 Late breaking trial session. June 26, 2020
    • iVascular COVID 19 letter June 15, 2020
    • iVascular – essential pro, new coronary drug coated balloon June 15, 2020
    • iVascular, innovation and passion at the interactive Vascular Summit 2020. March 2, 2020
    • TINTIN Trial 1-year outcomes presented at LINC 2020 January 30, 2020

    Categories

    • All
    • Clinical Trials
    • Congresses
    • Coronary
    • Coronary and peripheral news
    • Partnership
    • Peripheral
    iVascular Advanced Medical Devices and Therapies
    iVascular S.L.U. | Camí de Can Ubach, 11 (Pol. Ind. Les Fallulles)
    08620 Sant Vicenç dels Horts | Barcelona
    Tel.: +34 936 724 711 | Fax: +34 936 724 657
    Email: info@ivascular.global

    Privacy Policy | Cookie Policy | Legal Disclaimer

     #main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}

    Utilizamos cookies para garantizar la mejor experiencia en su navegación. Si continúa navegando considere aceptar el uso de cookies. Más información

    Privacy Preference Center

    • Política de Privacidad
    • Cookie Privacy

    Consent Management

    Política de Privacidad

    Required
    IntroducciónLa presente Política de Privacidad ha sido desarrollada teniendo en cuenta lo dispuesto por la Ley Orgánica de Protección de Datos de carácter personal en vigor, así como por el Reglamento 2016/679 del Parlamento Europeo y del consejo del 27 de abril de 2016 relativo a la protección de las personas físicas en lo que respecta al tratamiento de datos personales y a la circulación de estos datos, en adelante el RGPD.Esta Política de Privacidad tiene por objeto poner en conocimiento de los titulares de los datos personales, respecto de los cuales se está recabando información, los aspectos específicos relativos al tratamiento sus datos, entre otras cosas, las finalidades de los tratamientos, los datos de contacto para ejercer los derechos que le asisten, los plazos de conservación de la información y las medidas de seguridad entre otras cosas.

    Cookie Privacy

    Required
    Sus principales funciones son:Llevar el control de usuarios: cuando un usuario introduce su nombre de usuario y contraseña, se almacena una cookie para que no tenga que estar introduciéndolas para cada página del servidor. Sin embargo, una cookie no identifica solo a una persona, sino a una combinación de computador-navegador-usuario. Conseguir información sobre los hábitos de navegación del usuario, e intentos de spyware (programas espía), por parte de agencias de publicidad y otros. Esto puede causar problemas de privacidad y es una de las razones por la que las cookies tienen sus detractores.

    Necessary

    Analytics

    Session-only

    Cookies Used

    Google Analytics

    Other